D. Sutherland

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Mahmoud S. Assaf, B. Bennett, R. Chopra, 2016, Clinical and Translational Medicine.

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison study

K. Papp, R. Kaufmann, K. Papp, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study

E. Hur, J. Kosek, A. Kivitz, 2019, Rheumatology and Therapy.

Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance

H. Liebman, W. McGehee, D. Sutherland, 1996, British journal of haematology.

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison study

K. Papp, D. Thaçi, D. Sutherland, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.